HRPK20110080B3 - Composition for treatment of skeletal and joint disorders - Google Patents
Composition for treatment of skeletal and joint disordersInfo
- Publication number
- HRPK20110080B3 HRPK20110080B3 HRP20110080AA HRP20110080A HRPK20110080B3 HR PK20110080 B3 HRPK20110080 B3 HR PK20110080B3 HR P20110080A A HRP20110080A A HR P20110080AA HR P20110080 A HRP20110080 A HR P20110080A HR PK20110080 B3 HRPK20110080 B3 HR PK20110080B3
- Authority
- HR
- Croatia
- Prior art keywords
- treatment
- extract
- composition
- preparation
- resin extract
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 208000012659 Joint disease Diseases 0.000 title abstract 2
- 208000020084 Bone disease Diseases 0.000 abstract 2
- 102000010445 Lactoferrin Human genes 0.000 abstract 2
- 108010063045 Lactoferrin Proteins 0.000 abstract 2
- 239000000307 commiphora myrrha gum Substances 0.000 abstract 2
- 239000000470 constituent Substances 0.000 abstract 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 abstract 2
- 229940078795 lactoferrin Drugs 0.000 abstract 2
- 235000021242 lactoferrin Nutrition 0.000 abstract 2
- 239000011347 resin Substances 0.000 abstract 2
- 229920005989 resin Polymers 0.000 abstract 2
- 206010003246 arthritis Diseases 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Pripravak za liječenje koštanih poremećaja i poremećaja zglobova sastoji se od smjese suhog ekstrakta smole tamjana, suhog ekstrakta smole smirne i suhog ekstrakta laktoferina. Sinergijska učinkovitost sastavnica ovog pripravka znatno je bolja od zbroja učinkovitosti njegovih pojedinačnih sastavnica. Najbolji rezultati liječenja koštanih poremećaja kao što su artritis i artroza postižu se pripravkom u kojemu su ekstrakt smole tamjana, ekstrakt smole smirne i ekstrakt laktoferina zastupljeni u približnim težinskim omjerima 2:2:1. Pripravak se uzima oralno u formi tableta ili kapsula.The preparation for the treatment of bone disorders and joint disorders consists of a mixture of a dry incense resin extract, a myrrh resin extract and a lactoferrin dry extract. The synergistic efficacy of the constituents of this preparation is significantly better than the sum of the efficacy of its individual constituents. Best results in the treatment of bone disorders such as arthritis and arthrosis are achieved with a composition in which incense resin extract, myrrh resin extract, and lactoferrin extract are presented in approximate weight ratios of 2: 2. The preparation is taken orally in the form of tablets or capsules.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HRP20110080AA HRPK20110080B3 (en) | 2011-02-02 | 2011-02-02 | Composition for treatment of skeletal and joint disorders |
| PCT/HR2012/000002 WO2012104663A1 (en) | 2011-02-02 | 2012-01-24 | Composition for treatment of bone and joint disorders |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HRP20110080AA HRPK20110080B3 (en) | 2011-02-02 | 2011-02-02 | Composition for treatment of skeletal and joint disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP20110080A2 HRP20110080A2 (en) | 2012-08-31 |
| HRPK20110080B3 true HRPK20110080B3 (en) | 2014-01-03 |
Family
ID=46602108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20110080AA HRPK20110080B3 (en) | 2011-02-02 | 2011-02-02 | Composition for treatment of skeletal and joint disorders |
Country Status (2)
| Country | Link |
|---|---|
| HR (1) | HRPK20110080B3 (en) |
| WO (1) | WO2012104663A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104606585A (en) * | 2015-02-13 | 2015-05-13 | 焦振华 | Traditional Chinese medicine preparation for treating reactive osteoarthritis and preparation method thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0248534A (en) | 1988-07-28 | 1990-02-19 | Bio Serae Sa:Soc | Method for compounding antibacterial composition and compounded antibacterial composition |
| JP3184923B2 (en) | 1992-01-08 | 2001-07-09 | ビオ セレ ラボラトワール エス ア | Anti-rheumatic drug |
| WO2002085921A2 (en) * | 2001-03-01 | 2002-10-31 | Johann Jauch | Simple method for the synthesis of boswellic acids and derivatives thereof |
| EP1952818A4 (en) | 2005-10-27 | 2009-10-21 | Sunstar Inc | Inhibitor of osteoclast formation, composition for oral administration and prophylactic or therapeutic agent for bone disease comprising lactoferrin-containing liposome |
| CN100518763C (en) * | 2006-09-01 | 2009-07-29 | 胡庆华 | Chinese medicine for treating bone pain or anesthesia caused by cold and dampness |
| CN100502929C (en) * | 2007-02-06 | 2009-06-24 | 程宝良 | Nourishing and Nourishing Yin Zhubi Pills |
-
2011
- 2011-02-02 HR HRP20110080AA patent/HRPK20110080B3/en not_active IP Right Cessation
-
2012
- 2012-01-24 WO PCT/HR2012/000002 patent/WO2012104663A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012104663A1 (en) | 2012-08-09 |
| HRP20110080A2 (en) | 2012-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX343687B (en) | Tricyclic sulfonamide compounds and methods of making and using same. | |
| PH12013502261A1 (en) | Partially saturated tricyclic compounds and methods of making and using same | |
| MX343688B (en) | Tricyclic pyrazole sulfonamide compounds and methods of making and using same. | |
| CL2013002210A1 (en) | Prebiotic formulation for human consumption comprising 2'-fucosylactose, 3'-sialylactose and 6'-sialylactose, in which the amount by weight of 3'-sialylactose is at least as high as the amount of 2'-fucosylactose; and method to modulate or stimulate the proliferation of bifidobacteria in the human intestine. | |
| MY196319A (en) | Polycyclic TLR7/8 Antagonists and use Thereof in the Treatment of Immune Disorders | |
| CO6680658A2 (en) | Gpr 40 agonist | |
| MX2014008705A (en) | Tricyclic sulfone compounds and methods of making and using same. | |
| EA201791702A1 (en) | THERAPEUTIC TOOLS ON THE BASIS OF GLYCANS AND RELATED METHODS | |
| MX2014008706A (en) | Tricyclic sulfonamide compounds and methods of making and using same. | |
| SG10201808104RA (en) | Cenicriviroc for the treatment of fibrosis | |
| MX339201B (en) | Sulphonamide compounds and methods of making and using same. | |
| CO6690805A2 (en) | 6-amino-nicotinamides substituted as modular of kcnq2 / 3 | |
| MX2021015256A (en) | MIXTURE OF PLANT EXTRACTS FOR USE IN THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY INTESTINAL DISEASES. | |
| SG10201806854XA (en) | Compositions comprising 15-ohepa and methods of using the same | |
| WO2016190683A8 (en) | Composition for preventing and treating muscle diseases or improving muscular function, containing platycodon grandiflorum extract | |
| MX2014004694A (en) | Compositions. | |
| CR20130602A (en) | NEW COMPOUNDS AS INHIBITORS OF DIACILGLICEROL ACILTRANSFERASA | |
| MA47080A (en) | PREPARATION OF A DRY BIOMASS EXTRACT RICH IN POLYPHENOLS | |
| MY171048A (en) | Pharmaceutical composition for preventing or treating amyloid beta peptide-associated diseases or conditions | |
| WO2013184879A3 (en) | Pumpable fat compositions | |
| HRPK20110080B3 (en) | Composition for treatment of skeletal and joint disorders | |
| WO2016195194A3 (en) | Novel tlr2 antagonists | |
| WO2015044961A3 (en) | Pharmaceutical composition comprising capecitabine and cyclophosphamide | |
| AR066936A1 (en) | 3 - (2R - TETRAHYDROFURIL - METHYL) - 2 - THIOXANTINE. PHARMACEUTICAL COMPOSITIONS. | |
| PH12017500743A1 (en) | Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| AKOB | Publication of a request for the grant of a patent not including a substantive examination of a patent application (a consensual patent) | ||
| PKB1 | Consensual patent granted | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20190125 Year of fee payment: 9 |
|
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20200128 Year of fee payment: 10 |
|
| PK10 | Patent expired after termination of 10 years for consensual patent |
Effective date: 20210202 |